Entering text into the input field will update the search result below

Chelsea's Northera NDA reportedly approved, shares halted

  • Chelsea Therapeutics (NASDAQ:CHTP) is halted; multiple sources say Northera was approved by the FDA, but there's still no official press release from the FDA or the company.
  • A decision for the Northera new drug application was postponed from last Friday due to an office closure caused by severe weather.

Recommended For You

Related Stocks

SymbolLast Price% Chg
CHTP--
Chelsea Therapeutics International, Ltd.